• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evidence and recommendations for imaging liver fat in children, based on systematic review.基于系统评价的儿童肝脏脂肪成像的证据与建议
Clin Gastroenterol Hepatol. 2014 May;12(5):765-73. doi: 10.1016/j.cgh.2013.09.050. Epub 2013 Sep 30.
2
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.用于诊断神经母细胞瘤的123I-间碘苄胍闪烁扫描术和18F-氟代脱氧葡萄糖正电子发射断层显像
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
3
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
4
Carbon dioxide detection for diagnosis of inadvertent respiratory tract placement of enterogastric tubes in children.用于诊断儿童肠胃管意外置入呼吸道的二氧化碳检测
Cochrane Database Syst Rev. 2025 Feb 19;2(2):CD011196. doi: 10.1002/14651858.CD011196.pub2.
5
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.
6
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.瞬时弹性成像技术用于诊断酒精性肝病患者的肝纤维化和肝硬化分期。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
7
Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.超声检查在酒精性肝病患者中对酒精性肝硬化的诊断作用
Cochrane Database Syst Rev. 2016 Mar 2;3(3):CD011602. doi: 10.1002/14651858.CD011602.pub2.
8
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
9
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.
10
Effectiveness and safety of vitamin D in relation to bone health.维生素D对骨骼健康的有效性与安全性。
Evid Rep Technol Assess (Full Rep). 2007 Aug(158):1-235.

引用本文的文献

1
Markers of Early Liver Dysfunction Associate With Reduced Heart Rate Variability in Adolescents With Type 1 Diabetes.早期肝功能障碍标志物与1型糖尿病青少年心率变异性降低相关。
Pediatr Diabetes. 2025 May 15;2025:1910554. doi: 10.1155/pedi/1910554. eCollection 2025.
2
Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025.肥胖儿童的代谢功能障碍相关脂肪性肝病(MASLD):肥胖医学协会(OMA)与专家联合观点(2025年)
Obes Pillars. 2025 Feb 1;14:100164. doi: 10.1016/j.obpill.2025.100164. eCollection 2025 Jun.
3
Evaluating Pediatric NAFLD with Controlled Attenuation Parameter: A Comprehensive Narrative Review.使用受控衰减参数评估儿童非酒精性脂肪性肝病:一项全面的叙述性综述。
Diagnostics (Basel). 2025 Jan 27;15(3):299. doi: 10.3390/diagnostics15030299.
4
Pediatric MASLD: current understanding and practical approach.小儿 MASLD:当前认识与实用方法。
Eur J Pediatr. 2024 Nov 19;184(1):29. doi: 10.1007/s00431-024-05848-1.
5
Converging Pathways between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Diabetes in Children.代谢功能障碍相关脂肪性肝病(MASLD)与儿童糖尿病之间的交汇途径。
Int J Mol Sci. 2024 Sep 14;25(18):9924. doi: 10.3390/ijms25189924.
6
TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者临床评估与管理的TASL实践指南。
Hepatol Forum. 2023 Mar 15;4(Suppl 1):1-32. doi: 10.14744/hf.2023.2023.0011. eCollection 2023.
7
Risk factors and cardio-metabolic outcomes associated with metabolic-associated fatty liver disease in childhood.儿童代谢相关脂肪性肝病的危险因素及心脏代谢结局
EClinicalMedicine. 2023 Oct 6;65:102248. doi: 10.1016/j.eclinm.2023.102248. eCollection 2023 Nov.
8
Clinical epidemiology of non-alcoholic fatty liver disease in children and adolescents. The LiverKids: Study protocol.儿童和青少年非酒精性脂肪性肝病的临床流行病学。LiverKids:研究方案。
PLoS One. 2023 Oct 13;18(10):e0286586. doi: 10.1371/journal.pone.0286586. eCollection 2023.
9
Accuracy of attenuation coefficient measurement (ACM) for real-time ultrasound hepatic steatometry: Comparison of simulator/phantom data with magnetic resonance imaging proton density fat fraction (MRI-PDFF).实时超声肝脏脂肪定量中衰减系数测量(ACM)的准确性:模拟器/体模数据与磁共振成像质子密度脂肪分数(MRI-PDFF)的比较。
Heliyon. 2023 Oct 4;9(10):e20642. doi: 10.1016/j.heliyon.2023.e20642. eCollection 2023 Oct.
10
Distinguishing Autoimmune Hepatitis From Steatohepatitis in Adolescents With Obesity and Positive Screening Alanine Aminotransferase.区分肥胖且筛查丙氨酸氨基转移酶呈阳性的青少年自身免疫性肝炎与脂肪性肝炎
JPGN Rep. 2023 Feb 28;4(2):e292. doi: 10.1097/PG9.0000000000000292. eCollection 2023 May.

本文引用的文献

1
Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.肝脂肪变性:质子密度脂肪分数磁共振成像与肝活检的定量比较。
Radiology. 2013 Jun;267(3):767-75. doi: 10.1148/radiol.13121360. Epub 2013 Feb 4.
2
Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.磁共振成像测量肝脂肪分数的可重复性。
J Magn Reson Imaging. 2013 Jun;37(6):1359-70. doi: 10.1002/jmri.23928. Epub 2012 Nov 21.
3
Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children.超声检查作为一种非侵入性工具,用于检测超重/肥胖埃及儿童的非酒精性脂肪肝疾病。
Eur J Radiol. 2012 Nov;81(11):3120-3. doi: 10.1016/j.ejrad.2012.06.020. Epub 2012 Jul 18.
4
Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration.质子密度脂肪分数:一种基于磁共振成像的标准化组织脂肪浓度生物标志物。
J Magn Reson Imaging. 2012 Nov;36(5):1011-4. doi: 10.1002/jmri.23741. Epub 2012 Jul 6.
5
(1)H MRS assessment of hepatic steatosis in overweight children and adolescents: comparison between 3T and open 1T MR-systems.(1)超重儿童和青少年肝脏脂肪变性的氢质子磁共振波谱评估:3T与开放式1T磁共振系统的比较
Abdom Imaging. 2013 Apr;38(2):315-9. doi: 10.1007/s00261-012-9930-2.
6
US cannot be used to predict the presence or severity of hepatic steatosis in severely obese adolescents.美国不能用于预测严重肥胖青少年肝脂肪变性的存在或严重程度。
Radiology. 2012 Jan;262(1):327-34. doi: 10.1148/radiol.11111094. Epub 2011 Nov 21.
7
Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy.磁共振成像和波谱对肝脏脂肪的定量评估
J Magn Reson Imaging. 2011 Oct;34(4):729-749. doi: 10.1002/jmri.22775. Epub 2011 Sep 16.
8
In vivo characterization of the liver fat ¹H MR spectrum.体内¹H 磁共振波谱对肝脏脂肪的特征分析。
NMR Biomed. 2011 Aug;24(7):784-90. doi: 10.1002/nbm.1622. Epub 2010 Dec 12.
9
T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease.T1 加权双回波 MRI 用于儿科非酒精性脂肪性肝病的脂肪定量。
World J Gastroenterol. 2011 Jul 7;17(25):3012-9. doi: 10.3748/wjg.v17.i25.3012.
10
Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD.超声定量评估儿童非酒精性脂肪性肝病的肝脂肪变。
J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):190-5. doi: 10.1097/MPG.0b013e31821b4b61.

基于系统评价的儿童肝脏脂肪成像的证据与建议

Evidence and recommendations for imaging liver fat in children, based on systematic review.

作者信息

Awai Hannah I, Newton Kimberly P, Sirlin Claude B, Behling Cynthia, Schwimmer Jeffrey B

机构信息

Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, California; Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, California; Liver Imaging Group, Department of Radiology, University of California, San Diego School of Medicine, San Diego, California.

Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, California; Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, California.

出版信息

Clin Gastroenterol Hepatol. 2014 May;12(5):765-73. doi: 10.1016/j.cgh.2013.09.050. Epub 2013 Sep 30.

DOI:10.1016/j.cgh.2013.09.050
PMID:24090729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3969892/
Abstract

BACKGROUND & AIMS: Fatty liver is a common problem in children and increases their risk for cirrhosis, diabetes, and cardiovascular disease. Liver biopsy is the clinical standard for diagnosing and grading fatty liver. However, noninvasive imaging modalities are needed to assess liver fat in children. We performed a systematic review of studies that evaluated imaging liver fat in children.

METHODS

We searched PubMed for original research articles in peer-reviewed journals from January 1, 1982, through December 31, 2012, using the key words "imaging liver fat." Studies included those in English, and those performed in children from birth to 18 years of age. To be eligible for inclusion, studies were required to measure hepatic steatosis via an imaging modality and a quantitative comparator as the reference standard.

RESULTS

We analyzed 9 studies comprising 610 children; 4 studies assessed ultrasonography and 5 studies assessed magnetic resonance imaging (MRI). Ultrasonography was used in the diagnosis of fatty liver with positive predictive values of 47% to 62%. There was not a consistent relationship between ultrasound steatosis score and the reference measurement of hepatic steatosis. Liver fat as measurements by MRI or by spectroscopy varied with the methodologies used. Liver fat measurements by MRI correlated with results from histologic analyses, but sample size did not allow for an assessment of diagnostic accuracy.

CONCLUSIONS

Available evidence does not support the use of ultrasonography for the diagnosis or grading of fatty liver in children. Although MRI is a promising approach, the data are insufficient to make evidence-based recommendations regarding its use in children for the assessment of hepatic steatosis.

摘要

背景与目的

脂肪肝在儿童中是一个常见问题,会增加他们患肝硬化、糖尿病和心血管疾病的风险。肝活检是诊断和评估脂肪肝分级的临床标准。然而,需要非侵入性成像方法来评估儿童的肝脏脂肪情况。我们对评估儿童肝脏脂肪成像的研究进行了系统评价。

方法

我们在PubMed上检索了1982年1月1日至2012年12月31日期间同行评审期刊上的原创研究文章,使用关键词“肝脏脂肪成像”。研究包括英文研究以及针对从出生到18岁儿童开展的研究。为符合纳入标准,研究需通过一种成像方法测量肝脂肪变性,并以定量比较器作为参考标准。

结果

我们分析了9项研究,共610名儿童;4项研究评估了超声检查,5项研究评估了磁共振成像(MRI)。超声检查用于脂肪肝诊断时的阳性预测值为47%至62%。超声脂肪变性评分与肝脂肪变性的参考测量值之间没有一致的关系。通过MRI或光谱学测量的肝脏脂肪因所使用的方法而异。MRI测量的肝脏脂肪与组织学分析结果相关,但样本量不足以评估诊断准确性。

结论

现有证据不支持将超声检查用于儿童脂肪肝的诊断或分级。虽然MRI是一种有前景的方法,但数据不足以就其在儿童中用于评估肝脂肪变性提出基于证据的建议。